The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Jolley, John David Raby, Dr
    Independent Consultant born in March 1945
    Individual (8 offsprings)
    Officer
    2013-09-26 ~ dissolved
    OF - Director → CIF 0
    Dr John David Raby Jolley
    Born in March 1945
    Individual (8 offsprings)
    Person with significant control
    2016-09-26 ~ dissolved
    PE - Has significant influence or controlCIF 0
Ceased 3
  • 1
    Bird, Thomas Gary, Dr
    Independent Consultant born in March 1952
    Individual
    Officer
    2013-09-26 ~ 2019-11-01
    OF - Director → CIF 0
  • 2
    Borissov, Borislav Nikolaev, Dr
    Company Director born in May 1964
    Individual
    Officer
    2014-01-01 ~ 2020-02-20
    OF - Director → CIF 0
  • 3
    Martini, Luigi Gerard, Dr
    Non Executive Director born in February 1969
    Individual (11 offsprings)
    Officer
    2014-01-01 ~ 2020-02-20
    OF - Director → CIF 0
parent relation
Company in focus

PHARMA CONSULT GLOBAL LIMITED

Standard Industrial Classification
86210 - General Medical Practice Activities
86220 - Specialists Medical Practice Activities
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Current Assets
3,087 GBP2019-12-31
4,063 GBP2018-12-31
Creditors
Amounts falling due within one year
-10,534 GBP2019-12-31
-56,592 GBP2018-12-31
Net Current Assets/Liabilities
-7,447 GBP2019-12-31
-51,278 GBP2018-12-31
Total Assets Less Current Liabilities
-7,447 GBP2019-12-31
-51,278 GBP2018-12-31
Net Assets/Liabilities
-8,900 GBP2019-12-31
-52,389 GBP2018-12-31
Equity
-8,900 GBP2019-12-31
-52,389 GBP2018-12-31

  • PHARMA CONSULT GLOBAL LIMITED
    Info
    Registered number 08708196
    C/o R Walters & Co Suite A, 4-6 Canfield Place, London NW6 3BT
    Private Limited Company incorporated on 2013-09-26 and dissolved on 2020-09-29 (7 years). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.